Structure–activity relationships for the G-quadruplex-targeting experimental drug QN-302 and two analogues probed with comparative transcriptome profiling and molecular modeling

Ahmed Abdullah Ahmed,Shuang Chen,Maria Roman-Escorza,Richard Angell,Sally Oxenford,Matthew McConville,Naomi Barton,Mihiro Sunose,Dan Neidle,Shozeb Haider,Tariq Arshad,Stephen Neidle
DOI: https://doi.org/10.1038/s41598-024-54080-2
IF: 4.6
2024-02-13
Scientific Reports
Abstract:The tetrasubstituted naphthalene diimide compound QN-302 binds to G-quadruplex (G4) DNA structures. It shows high potency in pancreatic ductal adenocarcinoma (PDAC) cells and inhibits the transcription of cancer-related genes in these cells and in PDAC animal models. It is currently in Phase 1a clinical evaluation as an anticancer drug. A study of structure–activity relationships of QN-302 and two related analogues (CM03 and SOP1247) is reported here. These have been probed using comparisons of transcriptional profiles from whole-genome RNA-seq analyses, together with molecular modelling and molecular dynamics simulations. Compounds CM03 and SOP1247 differ by the presence of a methoxy substituent in the latter: these two compounds have closely similar transcriptional profiles. Whereas QN-302 (with an additional benzyl-pyrrolidine group), although also showing down-regulatory effects in the same cancer-related pathways, has effects on distinct genes, for example in the hedgehog pathway. This distinctive pattern of genes affected by QN-302 is hypothesized to contribute to its superior potency compared to CM03 and SOP1247. Its enhanced ability to stabilize G4 structures has been attributed to its benzyl-pyrrolidine substituent fitting into and filling most of the space in a G4 groove compared to the hydrogen atom in CM03 or the methoxy group substituent in SOP1247.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the mechanism of action of compound QN - 302 and its two analogs (CM03 and SOP1247) in targeting G - quadruplex (G4) DNA structures and their effects on pancreatic ductal adenocarcinoma (PDAC) cells through structure - activity relationship (SAR) studies. Specifically, the paper explores the differences between these compounds by comparing transcriptome profiling (using whole - genome RNA - seq analysis) as well as molecular modeling and molecular dynamics simulations, and explains why QN - 302 exhibits higher potency in inhibiting cancer - related gene expression. ### Research Background - **G - quadruplex (G4)**: It is a high - level structure formed by guanine (G) - rich sequences, commonly found in the human genome, especially in the promoters and untranslated regions of many cancer - related genes. - **QN - 302**: It is a tetrasubstituted naphthalene diimide compound that can bind to G4 DNA structures, shows high toxicity to PDAC cells, and inhibits the transcription of cancer - related genes in these cells. It is currently in the clinical phase 1a evaluation stage. - **CM03 and SOP1247**: They are two analogs of QN - 302, with different substituents at the 4 - position, namely a methoxy group and a benzylpyrrolidinyl group respectively. ### Research Objectives - **Structure - activity relationship (SAR)**: By comparing the transcriptome profiles of QN - 302, CM03 and SOP1247 in PDAC cell lines, as well as molecular modeling and molecular dynamics simulations, to reveal how the structural differences between these compounds affect their biological activities. - **Explain the high potency of QN - 302**: To explore why QN - 302 is more effective than CM03 and SOP1247 in inhibiting cancer - related gene expression. ### Main Findings - **Cytotoxicity**: The cytotoxicity of QN - 302 in PDAC cell lines is significantly higher than that of CM03 and SOP1247. - **Transcriptome Profile**: The number of genes affected by QN - 302 is less than that of CM03 and SOP1247, indicating that QN - 302 has higher selectivity. - **Down - regulation of Specific Genes**: QN - 302 specifically down - regulates some key genes, such as GLI1 (the main transcription factor in the Hedgehog signaling pathway), while CM03 and SOP1247 mainly affect the GLI4 gene. - **Molecular Modeling and Dynamics Simulation**: The benzylpyrrolidinyl group of QN - 302 can be better embedded in the groove of G4, enhancing its ability to stabilize the G4 structure, thereby increasing its biological activity. ### Conclusion The high potency of QN - 302 may be attributed to the fact that its benzylpyrrolidinyl group can be better embedded in the groove of G4, enhancing its ability to stabilize the G4 structure, thereby more effectively inhibiting the expression of cancer - related genes. These findings provide an important theoretical basis for the development of more effective G4 - targeted anticancer drugs.